FLVCR1a Controls Cellular Cholesterol Levels through the Regulation of Heme Biosynthesis and Tricarboxylic Acid Cycle Flux in Endothelial Cells.

ALAS1 FLVCR1 FLVCR1a cholesterol endothelial cell heme heme synthesis

Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
26 Jan 2024
Historique:
received: 21 12 2023
revised: 19 01 2024
accepted: 23 01 2024
medline: 24 2 2024
pubmed: 24 2 2024
entrez: 24 2 2024
Statut: epublish

Résumé

Feline leukemia virus C receptor 1a (FLVCR1a), initially identified as a retroviral receptor and localized on the plasma membrane, has emerged as a crucial regulator of heme homeostasis. Functioning as a positive regulator of δ-aminolevulinic acid synthase 1 (ALAS1), the rate-limiting enzyme in the heme biosynthetic pathway, FLVCR1a influences TCA cycle cataplerosis, thus impacting TCA flux and interconnected metabolic pathways. This study reveals an unexplored link between FLVCR1a, heme synthesis, and cholesterol production in endothelial cells. Using cellular models with manipulated FLVCR1a expression and inducible endothelial-specific

Identifiants

pubmed: 38397386
pii: biom14020149
doi: 10.3390/biom14020149
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Italian Association for Cancer Research
ID : IG18857, IG24922, IG21408
Organisme : Ministry of Education, Universities and Research
ID : PRIN 2022XJNWRM
Organisme : Italian Regenerative Medicine Infrastructure (IRMI)
ID : CTN01_00177_888744

Auteurs

Marta Manco (M)

Molecular Biotechnology Center "Guido Tarone", Via Nizza 52, 10126 Torino, Italy.
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126 Torino, Italy.
Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, VIB, 3000 Leuven, Belgium.
Laboratory of Tumor Inflammation and Angiogenesis, Center for Cancer Biology, Department of Oncology, KU Leuven, 3000 Leuven, Belgium.

Giorgia Ammirata (G)

Molecular Biotechnology Center "Guido Tarone", Via Nizza 52, 10126 Torino, Italy.
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126 Torino, Italy.

Sara Petrillo (S)

Molecular Biotechnology Center "Guido Tarone", Via Nizza 52, 10126 Torino, Italy.
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126 Torino, Italy.

Francesco De Giorgio (F)

Molecular Biotechnology Center "Guido Tarone", Via Nizza 52, 10126 Torino, Italy.
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126 Torino, Italy.

Simona Fontana (S)

Molecular Biotechnology Center "Guido Tarone", Via Nizza 52, 10126 Torino, Italy.
Department of Oncology, University of Torino, Via Santena 5/bis, 10126 Torino, Italy.

Chiara Riganti (C)

Molecular Biotechnology Center "Guido Tarone", Via Nizza 52, 10126 Torino, Italy.
Department of Oncology, University of Torino, Via Santena 5/bis, 10126 Torino, Italy.

Paolo Provero (P)

Department of Neurosciences "Rita Levi Montalcini", University of Torino, Corso Massimo D'Azeglio 52, 10126 Torino, Italy.
Center for Omics Sciences, Ospedale San Raffaele IRCCS, Via Olgettina 60, 20132 Milan, Italy.

Sharmila Fagoonee (S)

Molecular Biotechnology Center "Guido Tarone", Via Nizza 52, 10126 Torino, Italy.
Institute of Biostructure and Bioimaging, CNR c/o Molecular Biotechnology Center "Guido Tarone", 10126 Torino, Italy.

Fiorella Altruda (F)

Molecular Biotechnology Center "Guido Tarone", Via Nizza 52, 10126 Torino, Italy.
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126 Torino, Italy.

Emanuela Tolosano (E)

Molecular Biotechnology Center "Guido Tarone", Via Nizza 52, 10126 Torino, Italy.
Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126 Torino, Italy.

Classifications MeSH